Chevron (NYSE:CVX) ranks among Warren Buffett’s favorite stocks and is Berkshire Hathaway’s fifth-largest position with total exposure of $18.6 billion.
While Buffett has recently slashed some of Berkshire’s holdings, including his stake in Apple, he has only trimmed Chevron by single-digit percentages this year.
Is this Buffett favorite a buy,
» Read more about: Will This Buffett Favorite Skyrocket Under Trump? »
Costco (NASDAQ:COST) has seen enormous success with its membership-driven wholesale approach to retail shopping.
Listed as the third-largest retailer in the world behind only Walmart and Amazon, Costco is an increasingly popular option among cost-conscious shoppers looking to stretch their household budgets by buying in bulk at low prices.
Famously,
Nvidia (NASDAQ: NVDA) has rapidly cemented its place as one of the most sought-after stocks after seizing the role of toll road through which all big tech must travel to enter the artificial intelligence ecosystem.
Recently, Nvidia drew interest from billionaire investor Paul Tudor Jones, who raised his position by a staggering 853% to 273,294 shares,
» Read more about: AI Powerhouse Sees 853% Increase From Connecticut Billionaire »
Berkshire Hathaway (NYSE:BRK.B) is arguably one of the most successful companies in American history. The conglomerate founded by Warren Buffett now owns stakes in both large public companies and several wholly-owned subsidiaries.
Berkshire itself has also been a remarkable investment vehicle for its shareholders, boasting a 30-year total return of over 3,000%.
» Read more about: The Magnificent 7 Have a New Trillion Dollar Rival »
Recently, an under-the-radar tech company has captured the interest of top-tier investment funds. Hedge funds have quietly been acquiring significant shares that displays a conviction in this company’s potential to redefine its market.
So, what’s the stock is it a buy on the dip?
Merck & Co. (NYSE: MRK) might be best known for its drugs like Keytruda and Gardasil, but those blockbusters haven’t been enough to get shareholders excited as the share price has fallen under water this year, down 6%.
It may well be a pharmaceutical powerhouse but recent price weakness suggests that Merck may be flying under the radar for investors,
Stan Druckenmiller and Paul Tudor Jones, both among the most successful traders ever, are now on the same side of a trade: shorting long-duration bonds.
This move is more than just a hedge but rather it’s a bet that interest rates are headed higher, and when these legendary traders make such strong statements,
» Read more about: Paul Tudor Jones Is Betting Big Against the Bond Market: How You Can Too. »
Imagine a business that has quietly dominated its industry for decades, steadily outperforming its rivals while keeping an impeccable balance sheet.
Add to the fact that it has thrived during economic downturns and periods of rising interest rates when its peers faded.
In recent years, it’s seen its earnings surge, boosted by both disciplined underwriting and a strong investment portfolio.
» Read more about: Why Is Warren Piling Into This Monster Insurer? »
As probably the world’s best-regarded stock picker, Warren Buffett isn’t usually associated with ETFs. Nevertheless, the legendary value investor’s portfolio at Berkshire Hathaway contains two ETFs, both of which track the S&P 500 index.
These two funds, namely SPY and VOO, account for a little over $45 billion of Berkshire’s total holdings. Why does Buffett own the S&P 500,
» Read more about: The ONLY Fund Buffett Recommends (hint, it’s not his own) »
While NVIDIA grabs the headlines, billionaire Stan Druckenmiller has pointed his canons towards Coherent Corp. (NASDAQ: COHR), making it the largest position in his portfolio. What is it about this stock that has warranted such a large stake and why did Stan put so many eggs in its basket?
» Read more about: Billionaire Puts This AI Stock #1 (Hint, it’s not Nvidia) »